Referenz zu japanischen Arzneimitteln und Behandlung in Japan
Japanische Produktnamen, Wirkstoffnamen, Zulassungsinhaber, Stärken und PMDA-Produktquellen werden zusammen mit offiziellen Aufnahmeinformationen japanischer Krankenhäuser für internationale Patienten geordnet. Verschreibungspflichtige Arzneimittel erfordern eine ärztliche Beurteilung und den passenden Versorgungsprozess.
Mainly used for high blood pressure and angina.
Used for selected inflammatory conditions such as atopic dermatitis and severe asthma, depending on formulation.
This Rybelsus oral-tablet record is for type 2 diabetes.
Sources and verification
Medicine and medical-travel information is presented with sources, verification dates and scope.
Official medicine sources
Japanese product names, manufacturers and strengths are matched to PMDA product-level records.
Official hospital information
Appointments, referrals, coordinators and language requirements are checked against hospital sources.
Document and verification dates
Official document dates and TOKYO MEDI verification dates are shown separately.
Scope of medical information
No remote prescribing and no ordinary ecommerce flow for prescription medicines.
Medizinische Forschung und Versorgung in Japan
Ausgewählte Entwicklungen der japanischen Medizinforschung werden mit überprüfbaren Quellen als Hintergrund für aktuelle Arzneimittel- und Versorgungsinformationen dargestellt.
Shinya Yamanaka · iPS cells
Awarded for the discovery that mature cells can be reprogrammed to become pluripotent.
Tasuku Honjo · cancer immunotherapy
Awarded jointly with James P. Allison for cancer therapy by inhibition of negative immune regulation.
Satoshi Ōmura · antiparasitic therapy
Awarded jointly with William C. Campbell for discoveries concerning a novel therapy against roundworm infections.
Referenz japanischer Arzneimittel
Nach japanischem Produktnamen, Wirkstoff, Zulassungsinhaber, Stärke, Therapiegebiet und Primärquelle geordnet.
Datenbank durchsuchen
Nur Referenz · kein Onlinekauf
Windshear / CC BY-SA 4.0Rybelsus
リベルサス錠3mg／7mg／14mgThis Rybelsus oral-tablet record is for type 2 diabetes.
View medicine →Lyall0 / CC BY-SA 4.0Dupixent
デュピクセント皮下注300mg／200mg ペン・シリンジUsed for selected inflammatory conditions such as atopic dermatitis and severe asthma, depending on formulation.
View medicine →
松岡明芳 / CC BY-SA 4.0Rozerem
ロゼレム錠8mgUsed to improve difficulty falling asleep in insomnia.
View medicine →PETMEDIC PRONorvasc
ノルバスク錠2.5mg／5mg／10mg・ノルバスクOD錠2.5mg／5mg／10mgMainly used for high blood pressure and angina.
View medicine →
BMS Oncology JapanOpdivo
オプジーボ点滴静注20mg／100mg／120mg／240mgUsed for selected cancers, including melanoma, lung and kidney cancer, under disease-specific conditions.
View medicine →
エーザイ MedicalLeqembi
レケンビ点滴静注200mg／500mgUsed to slow progression of mild cognitive impairment or mild dementia due to Alzheimer’s disease.
View medicine →Gesundheit & Ernährung
Gesundheitslebensmittel und Nahrungsergänzungsmittel werden von Arzneimitteln getrennt und mit Lebensmittelstatus, Packungsgröße und Quellen gekennzeichnet.
Japan Deep-Sea Fish Collagen Peptide
View product →
DHC Blood Sugar Double Support
View product →
DHC Calcium + CBP
View product →
DHC Calcium / Magnesium
View product →Health foods and supplements are kept separate from medicines and are not presented as medicines.
Browse health & nutrition →Redaktionelle Grundsätze
Medicine records are organized from product-level official sources. Medical-travel content is limited to official hospital intake and system information. TOKYO MEDI does not provide personal medical consultation, appointments, diagnosis, prescribing or care coordination.
Offizielle Quelle →Primary sources first
Medicine status and hospital intake information are anchored to regulators, manufacturers and medical institutions.
Medical information separated from commerce
Prescription pages support reference and care pathways rather than ordinary shopping flows.
Organized for international readers
Multilingual names, Japanese system context and overseas-patient intake requirements are organized together.
Sources and verification dates shown
Official document dates and site verification dates are separated so readers can judge source and recency.
Medizinische Leitfäden
How to read official Japanese medicine information
Separate brand name, generic name, dosage form, prescription status and official documents before reading summaries.
Why prescription medicines and OTC medicines must be separated
Page structure, user journey and inquiry flow should not share one ecommerce pattern.
What medical records to prepare before travelling to Japan
Organize a medical summary, recent tests, imaging, medication list and translation needs before contacting a hospital.
Foreign approval does not equal Japanese availability
Approval in the US or another country does not automatically confer Japanese marketing authorization.
Behandlung in Japan
Prepare a diagnosis summary, recent reports, imaging and medication list.
Check referral, coordinator, international-patient and appointment requirements.
Translate the key documents requested by the receiving institution.
Clarify appointment, billing, payment and follow-up information before travel.
Institutional medicine inquiry
For institutions, pharmacies and companies only. Please provide institution details, medicine and strength, quantity, destination and relevant credentials. Personal prescription-medicine purchase requests and medical consultations are not accepted.
Referenz verschreibungspflichtiger Arzneimittel
